| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely hydroxyamfetamine hydrobromide 10 milligram/1 milliliter and tropicamide 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
2 |
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
1 |
| Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
3 |
| Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 2.5 mg/mL solution for injection |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
1 |
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
2 |
| Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
3 |
| Product containing precisely esterified estrogen 1.25 milligram and methyltestosterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
2,5 |
Inferred relationship |
Some |
2 |
| Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
2 |
| Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
2 |
| Lenalidomide 2.5 mg oral capsule |
har täljarvärde som visar styrka |
False |
2,5 |
Inferred relationship |
Some |
1 |
| Bilastine 2.5 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
2,5 |
Inferred relationship |
Some |
1 |